Literature DB >> 18058897

Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial.

David Kissane, Yuelin Li.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18058897     DOI： 10.1002/cncr.23179

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Emotion suppression and mortality risk over a 12-year follow-up.

Authors:  Benjamin P Chapman; Kevin Fiscella; Ichiro Kawachi; Paul Duberstein; Peter Muennig
Journal:  J Psychosom Res       Date:  2013-08-06       Impact factor: 3.006

2.  Cognitive behavioral symptom management intervention in patients with cancer: survival analysis.

Authors:  JiYeon Choi; Chien-Wen J Kuo; Alla Sikorskii; Mei You; Dianxu Ren; Paula R Sherwood; Charles W Given; Barbara A Given
Journal:  Support Care Cancer       Date:  2011-06-11       Impact factor: 3.603

3.  Living with metastatic breast cancer: a qualitative analysis of physical, psychological, and social sequelae.

Authors:  Catherine E Mosher; Courtney Johnson; Maura Dickler; Larry Norton; Mary Jane Massie; Katherine DuHamel
Journal:  Breast J       Date:  2013-03-26       Impact factor: 2.431

4.  Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making?

Authors:  Melanie A Price; Phyllis N Butow; Melanie L Bell; Anna deFazio; Michael Friedlander; Joanna E Fardell; Melinda M Protani; Penelope M Webb
Journal:  Support Care Cancer       Date:  2016-01-06       Impact factor: 3.603

5.  Spiritual Well-Being, Depression, and Quality of Life Among Latina Breast Cancer Survivors.

Authors:  O Garduño-Ortega; J Morales-Cruz; M Hunter-Hernández; F Gany; R Costas-Muñiz
Journal:  J Relig Health       Date:  2021-01-13

6.  Effect of a mentor-based, supportive-expressive program, Be Resilient to Breast Cancer, on survival in metastatic breast cancer: a randomised, controlled intervention trial.

Authors:  Zeng Jie Ye; Hong Zhong Qiu; Mu Zi Liang; Mei Ling Liu; Peng Fei Li; Peng Chen; Zhe Sun; Yuan Liang Yu; Shu Ni Wang; Zhang Zhang; Kun Lun Liao; Cai Fen Peng; Hui Huang; Guang Yun Hu; Yun Fei Zhu; Zhen Zeng; Qu Hu; Jing Jing Zhao
Journal:  Br J Cancer       Date:  2017-09-19       Impact factor: 7.640

Review 7.  Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β-adrenergic and cyclooxygenase 2 signaling.

Authors:  Itay Ricon; Tsipi Hanalis-Miller; Rita Haldar; Rebecca Jacoby; Shamgar Ben-Eliyahu
Journal:  Cancer       Date:  2018-10-06       Impact factor: 6.921
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.